Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Michael Walter

Michael Walter
Managing Editor


Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

A new use for IVL: helping cardiologists secure transcarotid access for TAVR
Cardiologists are first in world to use new cooling device to terminate AFib during surgery
Rates of obesity, high blood pressure and diabetes keep climbing in US
AI-enabled CCTA evaluations reduce use of invasive imaging exams
High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help
Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients
Stenting ‘an important treatment option’ for PCI patients with complete blockages
Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients
World’s first leadless LBBAP procedures linked to ‘promising’ outcomes
Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …87
    • Page 88
    • Page 89
    • Page 90
    • Current page 91
    • Page 92
    • Page 93
    • Page 94
    • Page 95 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme